IUS2:XETRA:XETRA-iShares S&P U.S. Banks UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.087

Change

-0.03 (-0.44)%

Market Cap

USD 0.33B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.66%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.88%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.27 (-0.95%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.08 (-0.76%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.66 (-1.44%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.65%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.23%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.62 (-0.27%)

USD 80.38B

ETFs Containing IUS2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.24% 92% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.24% 91% A- 90% A-
Trailing 12 Months  
Capital Gain 35.24% 92% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.24% 92% A 91% A-
Trailing 5 Years  
Capital Gain 30.75% 61% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.75% 57% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 16.91% 88% B+ 85% B
Dividend Return 16.91% 88% B+ 84% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 37.08% 7% C- 14% F
Risk Adjusted Return 45.62% 43% F 48% F
Market Capitalization 0.33B 56% F 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.